Regular physical activity and changes in risk factors for coronary heart disease: A nine months prospective study

European Journal of Clinical Chemistry and Clinical Biochemistry

Volumn 34, Issue 6, 1996, Pages 477-483

  Ponjee, Gabriëlle A E ^a   Janssen, Eugene M E ^c   Hermans, Jo ^b   Van Werseh, Jan W J ^d  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b Nederlands Sports Inst Geneeskunde   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d Sittard Geleen Heerlen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TRAINING; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD PRESSURE; CORONARY DISEASE; EXERCISE; FEMALE; FIBRINOLYSIS; HUMANS; LIPIDS; MALE; PHYSICAL FITNESS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0030055505     PISSN: 09394974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314:488-500.
2. Badimon JJ, Fuster V, Chesebro JH, Badimon L. Coronary atheroslcerosis; a multifactorial disease. Circulation 1993; 87 (II Suppl):35-165.
3. Strong JP. Atherosclerotic lesions; natural history, risk factors, and topography. Arch Pathol Lab Med 1992; 116:1268-75.
4. Von Rokitansky C. A manual of pathological anatomy. London, England: Sydenham Society 1852; 4:261.
5. Al-Hazzaa HM, Sulaiman MA, Al-Matar AJ, Al-Mobaireek KF. Cardiorespiratory fitness, physical activity patterns and coronary risk factors in préadolescent boys. Int J Sport Med 1994; 15:267-72.
6. Paffenbarger RS, Hyde RT, Wing AI, Lee IM, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993; 328:538-45.
7. Hâheim LL, Holme I, Hjermann I, Leren P. Risk factors of stroke incidence and morality; a 12-year follow-up of the Oslo study. Stroke 1993; 24:1484-9.
8. Marti B, Suter E, Riesen WF, Tschopp A, Wanner HU. Anthropométrie and lifestyle correlates of serum lipoprotein and apolipoprotein levels among normal non-smoking men and women. Atherosclerosis 1989; 75:111-22.
9. H0stmark AT, Berg J, Brudal S, Berge SR, Kierulf P, Bjerkedal T. Coronary risk factors in middle-aged men as related to smoking, coffee intake and physical activity. Scand J Soc Med 1992; 20:196-203.
10. Adamopoulos PN, Macrilakis K, Papamichael Ch, Malakos I, Panaydis N, Moulopoulos SpD. Physical activity and relationship with coronary heart disease risk factors. Acta Cardiol 1993; 6:523-34.
11. Hamsten A, Walldius G, Szamosi A, Blombäck M, De Faire U, Gahlén G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; i:3-9.
12. Elwood PC, Yarnell JWG, Pickering J, Fehily AM, O'Brien JR. Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly prospective Heart Disease Study. Br Heart J 1993; 69:183-7.
13. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Int Med 1993; 118:596-63.
14. Edelberg J, Pizzo SV. Why is lipoprotein(a) relevant to thrombosis? Am J Clin Nutr 1992; 56:791S-2S.
15. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990; 10:240-5.
16. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective casecontrol in a general population sample of middle aged men. BrMedJ 1990; 301:1248-51.
17. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339:303-5.
18. Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. N Engl J Med 1988; 319:1379-84.
19. Bovens AM, van Baak MA, Vrencken JG, Wijnen JA, Saris WH, Verstappen FT. Physical activity, fitness, and selected risk factors for CHD in active men and women. Med Sei Sports Exerc 1992; 5:572-6.
20. Bijnen FCH, Caspersen CJ, Mosterd WL. Physical inactivity as a risk factor for coronary heart disease: a WHO and International Society and Federation of Cardiology position statement. Bulletin WHO 1994; 72:1-4.
21. Lakka TA, Venäläinen JM, Rauramma R, Salonen R, Tuomolehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1994; 330:1549-54.
22. Mena P, Maynar M, Campillo JE. Plasma lipid concentrations in professional cyclists after competitive cycle races. Eur J Appl Physiol 1991; 62:349-52.
23. Streiff M, Bell WR. Exercise and hemostasis in humans. Semin Hematol 1994; 31:155-65.
24. Stray-Gundersen J, Denke MA, Grundy SM. Influence of lifetime cross-country skiing on plasma lipids and lipoproteins. Med Sei Sports Exerc 1991; 23:695-701.
25. Gough SCL, Whitworth S, Rice PJS, Grant PJ. The effect of exercise and heart rate on fibrinolytic activity. Blood Coagul Fibrinol 1992; 8:179-82.
26. Després JP, Tremblay A, Moorjani S, Lupien PJ, Thériault G, Nadeau A, et al. Long-term exercise training with constant energy intake. 3: effects on plasma lipoprotein levels. Int J Obes 1990; 14:85-94.
27. Findlay IN, Taylor RS, Dargie HJ, Grant S, Pettigrew AR, Wilson JT, et al. Cardiovascular effects of training for a marathon run in unfit middle aged men. Br Med J 1987; 295:521-4.
28. Superko HR. Exercise training, serum lipids, and lipoprotein particles: is there a change threshold? Med Sei Sports Exerc 1991; 23:677-85.
29. Thompson PD, Cullinane EM, Sady SP, Flynn MM, Bernier DN, Kantor MA, et al. Modest changes in high-density lipoprotein concentration and metabolism with prolonged exercise training. Circulation 1988; 78:25-34.
30. Stratton JR, Chandler WL, Schwanz RS, Cerqueira MD, Levy WC, Kahn SE, et al. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 1991; 83:1692-7.
31. Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Arteriosclerosis Thromb 1992; 12:780-8.
32. Young DR, Haskell WL, Jatulis DE, Fortmann SP. Associations between changes in physical activity and risk factors for coronary heart disease in a community-based sample of men and women: the Stanford Five-City project. Am J Epidemiol 1993; 138:205-16.
33. Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Caray SC, Willialms PT, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988; 319:1173-9.
34. Janssen GME. Marathon running: functional changes in male and female subjects during training and contests. Int J Sport Med 1989; 10 Suppl 3:117-90.
35. De Metz M, van Wersch JWJ. Use of a centrifugal analyzer for a chromogenic prothrombin time, a chromogenic activated partial thromboplastin time and a kinetic fibrinogen assay in a routine hospital laboratory. Haemostasis 1987; 17:254 -9.
36. Rijken DC, Juhan-Vague 1, DeCock F, Collen D. Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay. J Lab Clin Med 1983; 101:274.
37. Brändstorm A. Johnson O, Dahlen G, Ranby M. Lp(a) levels in a healthy population measured by a new enzyme linked immuno sorbent assay [abstract]. Thromb Haemost 1989; 62:573.
38. Chmielewska J, Wiman B. Determination of tissue plasminogen activator and its 'fast' inhibitor in plasma. Clin Chem 1986; 32:482-5.
39. Seigler L, Wu WT. Separation of serum high-density lipoprotein for cholesterol determination: ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride. Clin Chem 1981; 27:838-41.
40. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-509.
41. Grant S, Aitchison T, Pettigrew AR, Orrell JM. The effects of a university fitness programme on health-related variables in previously sedentary males. Br J Sports Med 1992; 26:39-44.
42. Stein PK, Boutcher SH. The effect of participation in an exercise training program on cardiovascular reactivity in sedentary middle-aged males. Int J Psychophysiol 1992; 13:215-23.
43. Arts FJP, Kuipers H. The relation between power output, oxygen uptake and heart rate in male athletes. Int J Sports Med 1994; 15:228-31.
44. Hawley JA, Noakes TD. Peak power output predicts maximal oxygen uptake and performance time in trained cyclists. J Appl Physiol 1992; 65:79-83.
45. Hellénius ML, de Faire U, Berglung B, Hamsten A, Krakau 1. Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors. Atheroslcerosis 1993; 103:81-91.
46. Gordon NF, Scott CB. Exercise and mild essential hypertension. Primary Care 1991; 18:683-94.
47. Blumenthal JA, Siegel WC, Appelbaum M. Failure of exercise to reduce blood pressure in patients with mild hypertension. J Am Med Ass 1991; 266:2098-104.
48. Seals DR, Hagberg JM. The effect of exercise training on human hypertension: a review. Med Sei Sports Exerc 1984; 16:207-15.
49. Gilders RM, Voner C, Dudley GA. Endurance training and blood pressure in normotensive and hypertensive adults. Med Sei Sports Exerc 1989; 21:629-36.
50. Greig HBW, Glasg MB. Inhibition of fibrinolysis by alimentary lipaemia. Lancet 1956; i:16-8.
51. Donders SHJ, Lustermans FATh, van Wersch JWJ. Fibrinolysis factors and lipid composition of the blood in treated and un-treated hypertensive patients. Blood Coagul Fibrinol 1992; 3:61-7.
52. Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglycéride concentrations. J Am Coll Cardiol 1987; 9:263-8.
53. Andersen P. Hypercoagulability and reduced fibrinolysis in hyperlipidaemia: relationship to the metabolic cardiovascular syndrome. J Cardiovascular Pharmacol 1992; 20 (Suppl 8):295-315.
54. Jansson JH, Johansson B, Boman K, Nilsson TK. Hypofibrinolysis in patients with hypertension and elevated cholesterol. J Int Med 1991; 229:309-16.
55. Urano T, Kojima Y, Takahashi M, Serizawa K, Sakakibara K, Takada Y, et al. Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma. Jpn J Physiol 1992; 43:221-8.
56. Ponjee GAE, Janssen GME, van Wersch JWJ. Prolonged endurance exercise and blood coagulation: a 9 month prospective study. Blood Coagul Fibrinol 1993; 4:21-5.
57. Ponjee GAE, Janssen GME, van Wersch JWJ. Effect of longterm endurance exercise on fibrinolytic markers. Fibrinolysis 1993; 7:397-400.
58. Ponjee GAE, Janssen GME, Hermans J, Van Wersch JWJ. Effects of long-term exercise of moderate intensity on anthropométrie values and serum lipids and lipoproteins. Eur J Clin Chem Clin Biochem 1995; 33:121-6.
59. Ponjee GAE, Janssen GME, Van Wersch JWJ. Long-term exercise and lipoprotein(a) levels in a previously sedentary male and female population. Ann Clin Biochem. 1995; 32:181-5.
60. Gris JC, Schved .IF, Aguilar-Martinez P, Arnaud A, Sanchez N. Impact of physical training on plasminogen activator inhibitor activity in sedentary men. Fibrinolysis 1990; 4 Suppl 2:97-8.
61. De Geus EJC, Kluft C, De Bart ACW, VanDoornen LJP. Effects of exercise training on plasminogen activator inhibitor activity. Med Sei Sports Exerc 1992; 24:1210-9.
62. Heinrich J, Sandkamp M, Kokott R, Schulte H, Assmann G. Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991; 37:1950-4.
63. Glueck CJ, Glueck HI, Tracy T, Speirs J, McGray C, Stroop D. Relationships between lipoprotein(a), lipids, apolipoproteins. basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism 1993; 42:236-46.
64. Halvorsen S, Skensberg OH, Berg K, Ruyter R, Godai HC. Does Lp(a) lipoprotein inhibit the fibrinolytic system? Thromb Res 1992; 68:223-32.
65. Oshima S, Uchida K., Yasu T, Uno K, Nonogi H, Haze K. Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Arterioscler Thromb 1991; 11:1772-7.
66. Cardoso GC, Posadas C, Orvananos OO, Péniche C, Zamora J, Aguilar R, et al. Long distance runners and body-builders exhibit elevated plasma levels of lipoprotein(a). Chem Phys Lipids 1994; 67/68:207-21.
67. Craig WY, Ledue TB. Lipoprotein(a) and the acute phase response. Clin Chim Acta 1992; 210:231-2.
68. Arai M, Yorifuji H, Ikematsu S, Nagasawa H, Fujimaji M, Fukutake K, et al. Influences of strenuous exercise (triathlon) on blood coagulation and fibrinolytic system. Throm Res 1990; 57:465-71.
69. Taniguchi N, Hirohiko, Yamauchik. Effects of treadmill exercise on platelet functions and blood coagulating activities in healthy men. Jpn Heart J 1984;26:167-80.